首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >During the Early Prediabetic Period in NOD Mice, the Pathogenic CD8(+) T-Cell Population Comprises Multiple Antigenic Specificities.
【24h】

During the Early Prediabetic Period in NOD Mice, the Pathogenic CD8(+) T-Cell Population Comprises Multiple Antigenic Specificities.

机译:在NOD小鼠的糖尿病前期早期,致病性CD8(+)T细胞群体包含多种抗原特异性。

获取原文
获取原文并翻译 | 示例
           

摘要

In the NOD mouse model of type 1 diabetes, major histocompatibilitycomplex (MHC) class I-restricted CD8(+) T cells are essential for disease development. However, the extent of diversity of their antigenic specificities during early pathogenesis remains unclear. An insulin-derived peptide was recently identified as the epitope for the NOD-derived diabetogenic T-cell clone G9C8. To explore the possibility that the early pathogenic CD8(+) T-cell population comprises additional antigenic specificities, we employed the T-cell clones AI4 and NY8.3, both of which are pathogenic and represent specificities present in early insulitic lesions. The clones responded to distinct fractions of chromatographically separated class I MHC-bound peptides purified from NOD-derived NIT-1 beta cells, and neither clone recognized the insulin-derived peptide. NIT-1 cells represent an unlimited peptide source that will allow for the future isolation and sequencing of the novel multiple epitopes targeted early in the autoimmune response by pathogenic CD8(+) T cells.
机译:在1型糖尿病的NOD小鼠模型中,主要的组织相容性复合体(MHC)I类限制性CD8(+)T细胞对于疾病发展至关重要。然而,在早期发病机理中其抗原特异性的多样性程度仍不清楚。最近,胰岛素衍生的肽被鉴定为NOD衍生的糖尿病性T细胞克隆G9C8的表位。为了探索早期致病性CD8(+)T细胞群包含其他抗原特异性的可能性,我们采用了T细胞克隆AI4和NY8.3,两者均具有致病性并代表早期绝缘性病变中存在的特异性。克隆对从NOD衍生的NIT-1β细胞纯化的色谱分离的I类MHC结合的肽的不同馏分作出反应,而这两个克隆均未识别出胰岛素衍生的肽。 NIT-1细胞代表着无限的肽源,它将允许未来分离和测序致病性CD8(+)T细胞在自身免疫应答中早期靶向的新型多个表位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号